Ads
related to: antibody
Search results
Earnings call: BioAtla reports promising data in cancer drug trials By Investing.com
Investing.com· 7 hours agoBioAtla, a biotechnology company, has announced its first-quarter financial results and provided a...
Nipocalimab's Unique Mechanism Gets Second Chance in RA
Medscape· 3 days agoThe IRIS-RA study of the investigational monoclonal antibody drug nipocalimab in patients with...
Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides...
WKRN Nashville· 3 hours agoScinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing ...
New clinical study of ‘next wave’ biotic shows versatile application potential
Nutraingredients.com· 4 hours agoA 2021 study by FMCG Gurus found that 64% of global consumers are now more conscious of immunity since the pandemic.1 The immune system is made up of components such as white blood cells, lymphocytes ...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 1 day agoMerck MRK announced that it is discontinuing a cohort of the phase III study evaluating a...
Nabla Bio secures $26m in Series A funding round
Pharmaceutical Technology via Yahoo Finance· 14 hours agoThey have long been considered the "holy grail" of protein drug development. Nabla’s generative protein design platform is now making hundreds of these...
Spyre Therapeutics names Sandra Milligan to board By Investing.com
Investing.com· 7 hours agoSpyre Therapeutics, Inc. (NASDAQ: SYRE), a biotechnology company focusing on the development of...
The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic Antibody Discovery
Casper Star-Tribune· 5 days agoThe Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx, an innovator in biotechnology, announced a strategic partnership to develop and commercialize ...
How Hazel Jones is charting new horizons in genomics
BioPharma-Reporter· 14 hours agoAlthough I have spent over 20 years in oncology drug discovery I have taken a leap of faith into a 3D genomics company. The current focus of Enhanced is...
What to know about the COVID-19 FLiRT variant as it spreads in Connecticut ahead of summer
The News-Times· 14 hours agoA new group of COVID-19 variants called “FLiRT” are rapidly becoming the dominant mutations of the...
Ad
related to: antibody
